{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T08:14:26Z","timestamp":1767946466093,"version":"3.49.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Human papillomavirus (HPV) infection is one of the most common sexually transmitted infections among women worldwide. The present study reports the prevalence and type distribution of HPV in the same hospital between 2019 and 2023, and analyzes the impact of the COVID-19 pandemic on HPV infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Female participants aged \u226518\u202fyears old were recruited from Aerospace Center Hospital in Beijing, China, between 2019 and 2023. A total of 27 HPV types were detected using fluorescence quantitative polymerase chain reaction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>37,225 women underwent at least one HPV test, with an overall positive rate of 10.22%. The HPV positive rates in the age groups of \u226445\u202fyears, 46\u201360\u202fyears, and &amp;gt;60\u202fyears were 9.44, 11.61, and 11.14%, respectively. By year, the positive rates were 5.19% in 2019, 11.60% between 2020 and 2022, and 9.37% in 2023. Women with uterine fibroids or a history of hysterectomy\/ovariohysterectomy had higher HPV positive rates than those without these conditions. Compared with the pre- and post-COVID-19 periods, the HPV positive rate was significantly higher during the pandemic (2020\u20132022). Among high-risk HPV types, the top five most prevalent ones (by positive case count) were HPV52, 16, 58, 53, and 56. For low-risk HPV, HPV61 had the highest positive rate from 2020 to 2023. Single-type HPV infection accounted for the highest proportion across all age groups and years. Joinpoint regression analysis showed that the HPV positive rate decreased sharply in the 31\u201335\u202fyears age group (Annual Percent Change [APC]\u202f=\u202f\u221222.2%, 95% Confidence Interval [CI]\u202f=\u202f\u221227.9\u202f~\u202f\u221213.1), then increased steadily until the 66\u201370\u202fyears age group (APC\u202f=\u202f6.9%, 95% CI\u202f=\u202f5.5\u202f~\u202f8.3), and declined again thereafter (APC\u202f=\u202f\u221218%, 95% CI\u202f=\u202f\u221225.4\u202f~\u202f\u22127.3).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>There may be a potential association between the COVID-19 pandemic and HPV transmission. Our findings provide valuable insights for optimizing HPV screening strategies and formulating HPV prevention measures. The association between gynecological diseases and specific HPV types requires further investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmicb.2025.1735393","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T06:36:45Z","timestamp":1767940605000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and type distribution of human papillomavirus in a Chinese urban population between 2019 and 2023: a retrospective study"],"prefix":"10.3389","volume":"16","author":[{"given":"Mei-Yan","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Jing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Yao","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-Kai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/fcimb.2019.00059","article-title":"Changes in cervical human papillomavirus (HPV) prevalence at a youth clinic in Stockholm, Sweden, a decade after the introduction of the HPV vaccine","volume":"9","author":"\u00c4hrlund-Richter","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.bjid.2017.01.009","article-title":"Prevalence and risk factors for human papillomavirus infection among Chinese ethnic women in southern Yunnan, China","volume":"21","author":"Balocha","year":"2017","journal-title":"Braz. J. Infect. Dis."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","article-title":"Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020","volume":"134","author":"Cao","year":"2021","journal-title":"Chin. Med. J."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.2147\/IJWH.S357140","article-title":"Overexpression of miR-3653 is associated with HPV infection and serves as a biomarker in patients with cervical cancer","volume":"14","author":"Cui","year":"2022","journal-title":"Int. J. Women's Health"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol."},{"key":"ref6","first-page":"247","article-title":"Prevalence, genotype distribution and temporal dynamics of human papillomavirus infection in a population in southern Italy","volume":"3","author":"Del Prete","year":"2017","journal-title":"Infez. Med."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"103290","DOI":"10.1016\/j.eclinm.2025.103290","article-title":"Global HPV vaccination programs and coverage rates: a systematic review","volume":"84","author":"Han","year":"2025","journal-title":"EClinicalMedicine"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ijgo.2015.04.027","article-title":"Prevalence and genotype distribution of HPV infection among women in Ningbo, China","volume":"131","author":"Hong","year":"2015","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12985-024-02447-2","article-title":"Prevalence and genotype distribution of human papillomavirus infection among 66000 women from 2014 to 2023 in the plateau region of Southwest China","volume":"21","author":"Hu","year":"2024","journal-title":"Virol. J."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"9374","DOI":"10.1038\/s41598-025-92102-9","article-title":"Multicenter study on the distribution and prevalence of human papillomavirus types in Hangzhou, Zhejiang from 2017 to 2023","volume":"15","author":"Ke","year":"2025","journal-title":"Sci. Rep."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12985-024-02393-z","article-title":"The prevalence and genotype distribution of human papillomavirus in Central Fujian Province during the COVID-19 pandemic","volume":"21","author":"Lin","year":"2024","journal-title":"Virol. J."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"799736","DOI":"10.3389\/fmed.2022.799736","article-title":"Impact of COVID-19 outbreak on the Gynecological outpatients HPV infection rate in Wuhan, China: a retrospective observational study","volume":"9","author":"Liu","year":"2022","journal-title":"Front. Med."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e70148","DOI":"10.1002\/cam4.70148","article-title":"Prevalence and genotype distribution of HPV combined with cervical pathological results in women from Sichuan, China: a cross-sectional study based on post-vaccination period 2019 to 2023","volume":"13","author":"Mo","year":"2024","journal-title":"Cancer Med."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e0122488","DOI":"10.1371\/journal.pone.0122488","article-title":"Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysis","volume":"10","author":"Ogembo","year":"2015","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.1038\/s41598-019-39790-2","article-title":"Screening for HPV infection in exfoliated cervical cells of women from different ethnic groups in Yili, Xinjiang, China","volume":"9","author":"Pan","year":"2017","journal-title":"Sci. Rep."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e22497","DOI":"10.1016\/j.heliyon.2023.e22497","article-title":"Human papillomavirus genotypes distribution and associated risk factors among women living in southern Morocco","volume":"9","author":"Rogua","year":"2023","journal-title":"Heliyon"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1080\/20477724.2023.2239052","article-title":"HPV and COVID-19 era: effects of nonpharmaceutical interventions on HPV transmission","volume":"117","author":"Ronga","year":"2023","journal-title":"Pathog. Glob. Health"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00292-012-1705-6","article-title":"Gyn\u00e4kopathologie-update [update on gynecopathology]","volume":"34","author":"Schmidt","year":"2013","journal-title":"Pathologe"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"7077","DOI":"10.7314\/APJCP.2015.16.16.7077","article-title":"Do human papilloma viruses play any role in Oral squamous cell carcinoma in north Indians?","volume":"16","author":"Singh","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.7150\/jca.30157","article-title":"Prevalence and characteristics of hrHPV infection among 414,540 women: a multicenter study in central and eastern China","volume":"10","author":"Wang","year":"2019","journal-title":"J. Cancer"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e0304760","DOI":"10.1371\/journal.pone.0304760","article-title":"Prevalence characteristics of cervical human papillomavirus infection in Chengdu and Aba District, Sichuan Province, China","volume":"19","author":"Wang","year":"2024","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1357311","DOI":"10.3389\/fpubh.2024.1357311","article-title":"Prevalence and genotype distribution of HPV infection from Hangzhou of Zhejiang Province pre- and during COVID-19 pandemic","volume":"12","author":"Wang","year":"2024","journal-title":"Front. Public Health"},{"key":"ref24","volume-title":"African health ministers, partners urge equitable access to critical tools to curb cervical cancer threat","year":"2024"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e8709","DOI":"10.7717\/peerj.8709","article-title":"Prevalence and type distribution of human papillomavirus in a Chinese urban population between 2014 and 2018: a retrospective study","volume":"8","author":"Xu","year":"2020","journal-title":"PeerJ"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e29155","DOI":"10.1002\/jmv.29155","article-title":"The impact of the COVID-19 pandemic on the prevalence and genotype distribution of HPV infection in Beijing, China","volume":"95","author":"Yi","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e70424","DOI":"10.1002\/jmv.70424","article-title":"Changes in the epidemiology of high-risk HPV genital tract infections among women in Shanghai: a pre- and post-COVID-19 pandemic analysis (2013-2024)","volume":"97","author":"Yu","year":"2025","journal-title":"J. Med. Virol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.apjtm.2017.01.007","article-title":"Expression and clinical significance of high-risk human papillomavirus and invasive gene in cervical carcinoma","volume":"10","author":"Zhai","year":"2017","journal-title":"Asian Pac J Trop Med"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12985-019-1175-z","article-title":"Distribution of human papillomavirus infection: a population-based study of cervical samples from Jiangsu Province","volume":"16","author":"Zhang","year":"2019","journal-title":"Virol. J."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12985-024-02497-6","article-title":"Influence of COVID-19 pandemic on prevalence and genotype distribution of HPV in cervical cancer screening population","volume":"21","author":"Zhang","year":"2024","journal-title":"Virol. J."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2329450","DOI":"10.1080\/21645515.2024.2329450","article-title":"Opportunities and challenges for human papillomavirus vaccination in China","volume":"20","author":"Zhao","year":"2024","journal-title":"Hum. Vaccin. Immunother."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1735393\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T06:36:46Z","timestamp":1767940606000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1735393\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":31,"alternative-id":["10.3389\/fmicb.2025.1735393"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2025.1735393","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"article-number":"1735393"}}